These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 28119137

  • 1. Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion.
    Gryglewski G, Rischka L, Philippe C, Hahn A, James GM, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A, Berroterán-Infante N, Nics L, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R.
    Neuroimage; 2017 Apr 01; 149():23-32. PubMed ID: 28119137
    [Abstract] [Full Text] [Related]

  • 2. Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR.
    Silberbauer LR, Gryglewski G, Berroterán-Infante N, Rischka L, Vanicek T, Pichler V, Hienert M, Kautzky A, Philippe C, Godbersen GM, Vraka C, James GM, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Hahn A, Lanzenberger R.
    Front Mol Neurosci; 2019 Apr 01; 12():172. PubMed ID: 31354428
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans.
    Frankle WG, Huang Y, Hwang DR, Talbot PS, Slifstein M, Van Heertum R, Abi-Dargham A, Laruelle M.
    J Nucl Med; 2004 Apr 01; 45(4):682-94. PubMed ID: 15073266
    [Abstract] [Full Text] [Related]

  • 4. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS, Ichise M, Sangare J, Innis RB.
    J Nucl Med; 2006 Feb 01; 47(2):208-14. PubMed ID: 16455625
    [Abstract] [Full Text] [Related]

  • 5. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M, Ehrlichmann W, Stahlschmidt A, Pichler BJ, Fischer K.
    J Nucl Med; 2016 Jan 01; 57(1):115-21. PubMed ID: 26514178
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
    Hillmer AT, Esterlis I, Gallezot JD, Bois F, Zheng MQ, Nabulsi N, Lin SF, Papke RL, Huang Y, Sabri O, Carson RE, Cosgrove KP.
    Neuroimage; 2016 Nov 01; 141():71-80. PubMed ID: 27426839
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In Vivo Evaluation of 11C-Preladenant for PET Imaging of Adenosine A2A Receptors in the Conscious Monkey.
    Zhou X, Boellaard R, Ishiwata K, Sakata M, Dierckx RAJO, de Jong JR, Nishiyama S, Ohba H, Tsukada H, de Vries EFJ, Elsinga PH.
    J Nucl Med; 2017 May 01; 58(5):762-767. PubMed ID: 28062599
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O, Becker GA, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Habermann B, Neuhaus P, Fischer S, Tiepolt S, Deuther-Conrad W, Barthel H, Schönknecht P, Brust P.
    Neuroimage; 2015 Sep 01; 118():199-208. PubMed ID: 26037057
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.
    Miller JM, Everett BA, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.
    Synapse; 2016 Jan 01; 70(1):24-32. PubMed ID: 26426356
    [Abstract] [Full Text] [Related]

  • 17. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG.
    Kim JH, Kim JH, Son YD, Joo YH, Lee SY, Kim HK, Woo MK.
    Schizophr Res; 2017 Apr 01; 182():55-65. PubMed ID: 27760700
    [Abstract] [Full Text] [Related]

  • 18. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG, Robertson B, Maier G, Paris J, Asmonga D, May M, Himes ML, Mason NS, Mathis CA, Narendran R.
    Synapse; 2018 Mar 01; 72(3):. PubMed ID: 29216407
    [Abstract] [Full Text] [Related]

  • 19. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
    Catafau AM, Pérez V, Penengo MM, Bullich S, Danús M, Puigdemont D, Pascual JC, Corripio I, Llop J, Perich J, Alvarez E.
    J Nucl Med; 2005 Aug 01; 46(8):1301-9. PubMed ID: 16085586
    [Abstract] [Full Text] [Related]

  • 20. PET measurement of "GABA shift" in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [18F]flumazenil.
    Kim W, Park HS, Moon BS, Lee BC, Kim SE.
    Nucl Med Biol; 2017 Feb 01; 45():30-34. PubMed ID: 27886620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.